SCHEMBL8790127

SCHEMBL8790127

C[C@H](N)C(=O)N1CCC(CC(=O)OCc2ccccc2)CC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
DPP4 P27487 4/20 0.40
KCNH2 Q12809 4/20 0.40
DPP7 Q9UHL4 4/20 0.40
PREP P48147 2/20 0.39
CYP3A4 P08684 7/20 0.39
CYP2C9 P11712 6/20 0.39
TSHR P16473 6/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
SLC15A1 P46059 1/20 0.39
CYP1A2 P05177 4/20 0.38
CYP2D6 P10635 2/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790582 1.00 CYP2C19 (0.41) CYP2C19SMN1; SMN2DPP4KCNH2DPP7
SCHEMBL7359194 0.84 SMN1; SMN2 (0.39) CYP2C19SMN1; SMN2TSHRALDH1A1MEN1
SCHEMBL7363294 0.82 SMN1; SMN2 (0.48) CYP2C19SMN1; SMN2DPP4KCNH2DPP7
SCHEMBL7363296 0.82 SMN1; SMN2 (0.48) CYP2C19SMN1; SMN2DPP4KCNH2DPP7
SCHEMBL8790914 0.80 BRD4 (0.34) SMN1; SMN2DPP4DPP7PREP
SCHEMBL8791441 0.77 SLC15A1 (0.40) CYP2C19SMN1; SMN2DPP4KCNH2DPP7
SCHEMBL10853040 0.73 ALDH1A1 (0.49) CYP2C19SMN1; SMN2ALDH1A1MAPK1
SCHEMBL26327917 0.73 HRH3 (0.48) CYP2C19SMN1; SMN2KCNH2ALDH1A1MAPK1
SCHEMBL22193270 0.72 LTA4H (0.48) CYP2C19SMN1; SMN2ALDH1A1MAPK1
SCHEMBL8790576 0.72 SMN1; SMN2 (0.46) CYP2C19SMN1; SMN2KCNH2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0800516-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1997-10-15 EP disclosed